Council of Institutional Investors

Section: January 13, 2022 | Vol 27, Issue 2
CII Members Rev Up Initiatives for 2022 Proxy Season
CII’s Shareholder Advocacy Committee hosted a proxy season preview webinar January 12 during which nine CII members shared their 2022 initiatives and 157 members and guests tuned in to listen.
2021 Sees Record “Zombie” Directors, Surge in Majority-Supported Shareholder Proposals, Say-on-Pay Failures
According to a CII analysis, the number of majority-supported shareholder proposals, directors who failed to receive majority support and say-on-pay failures all increased in 2021.
SEC Drafting Plan to Ramp Up Private Company Disclosures
The SEC is working on a plan to require more private companies to routinely disclose information about their finances and operations, according to a regulatory agenda published in December.
Activist Shareholders and Non-Profits Partner to Push Vaccine Manufacturers for Equitable Distribution
This proxy season, shareholders are targeting the pharmaceutical companies that manufacture Covid vaccines with proposals intended to ensure a wider, more equitable distribution of inoculations.
State Street CEO Provides Details on Asset Manager’s Approaches to Climate Change, Board Diversity
In his annual letter to investors about State Street Global Advisors’ (SSGA) voting agenda, SSGA President and CEO Cyrus Taraporevala explained how the asset manager will be monitoring its portfolio companies’ progress on net zero emissions and enhanced board diversity.
U.K. Regulator Launches Study on Pricing, Competition of Wholesale Data Providers
The Financial Conduct Authority (FCA), the regulator for 51,000 financial services firms and financial markets in the U.K., announced January 11 that it is launching two market studies to investigate access to wholesale data.
GOP Attorneys General File Brief Supporting Lawsuit Challenging Nasdaq Board Diversity Rule
A group of 17 Republican attorneys general led by Arizona Attorney General Mark Brnovich, has filed an amicus brief in support of a challenge to the SEC’s approval of a Nasdaq board diversity rule.